Back to today’s briefing

Story perspectives

U.S. Health Systems Ditch Race-Based Tools Amid Major Acquisitions

1/15/2025

37 6

Summary

Story summary

U.S. health systems are set to eliminate race-based clinical tools by May, responding to growing concerns about discrimination. In a significant move, Truveta has teamed up with Regeneron to boost data sales, while Nvidia is forging AI partnerships in healthcare. Meanwhile, Johnson & Johnson made headlines by acquiring Intra-Cellular Therapies for a staggering $14.6 billion during JPM Week.

1 of 1

Story summary

U.S. health systems are set to eliminate race-based clinical tools by May, responding to growing concerns about discrimination. In a significant move, Truveta has teamed up with Regeneron to boost data sales, while Nvidia is forging AI partnerships in healthcare. Meanwhile, Johnson & Johnson made headlines by acquiring Intra-Cellular Therapies for a staggering $14.6 billion during JPM Week.